ArticleBioengineered2021

The anti-tumor effects of evodiamine on oral squamous cell carcinoma (OSCC) through regulating advanced glycation end products (AGE) / receptor for advanced glycation end products (RAGE) pathway.

Liuyang Ren et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.